Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FLNC | Class A Common Stock | Options Exercise | $223K | +90.9K | +298.94% | $2.45* | 121K | Mar 2, 2023 | Direct | |
transaction | FLNC | Class A Common Stock | Sale | -$379K | -19.7K | -16.25% | $19.23 | 102K | Mar 2, 2023 | Direct | F1, F2 |
transaction | FLNC | Class A Common Stock | Sale | -$1.4M | -71.2K | -70.07% | $19.62 | 30.4K | Mar 3, 2023 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | FLNC | Stock Option | Options Exercise | $0 | -90.9K | -22.5% | $0.00 | 313K | Mar 2, 2023 | Class A Common Stock | 90.9K | $2.45 | Direct | F4 |
Id | Content |
---|---|
F1 | Proceeds from the sale were used to pay the exercise price of such portion of the stock option, pursuant to a broker-assisted cashless exercise, and applicable withholding taxes. |
F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple open market transactions at prices ranging from $19.2 to $19.305, inclusive. The Reporting Person undertakes to provide to Fluence, any security holder of Fluence, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range indicated in this footnote. |
F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple open market transactions at prices ranging from $19.2 to $20.06, inclusive. The Reporting Person undertakes to provide to Fluence, any security holder of Fluence, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range indicated in this footnote. |
F4 | Represents part of a single option award grant initially for an aggregate 403,893 shares, which vests in three equal annual installments. 1/3rd of the aggregate shares subject to the option became vested and exercisable on April 2, 2022. |